This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.
We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.
Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.
Resolved shortages
The following shortages have been resolved and supply has resumed to the Irish market:
| Product | Active Ingredient(s) |
| Doxorubicin Teva 2 mg/ml Concentrate for Solution for Infusion (100ml presentation) PA0749/083/001 Teva Pharma B.V. | Doxorubicin |
| Epilim Chronosphere 500mg prolonged-release granules PA0540/150/007 Sanofi-Aventis Ireland Limited T/A SANOFI | Sodium valproate |
| Exorex Lotion 5% v/w Cutaneous Emulsion PA1986/078/001 Teva B.V. | Coal tar solution |
| Leucovorin-Teva 10mg/ml Concentrate for Solution for Infusion (50mg/5ml) PA0749/001/001 Teva Pharma B.V. | Leucovorin |
| Methotrexate 5mg/2ml Injection PA0822/206/001 Pfizer Healthcare Ireland | Methotrexate |
| Neurostil 100 mg capsules, hard PA0749/164/001 Teva Pharma B.V. | Gabapentin |
| Nortem 20mg Tablets PA1986/085/002 Teva B.V. | Temazepam |
| Ozempic 1mg Solution for Injection in Pre-Filled Pen EU/1/17/1251/005 Novo Nordisk A/S | Semaglutide |
| Tavanic 500 mg film-coated tablets PA0540/077/003 Sanofi-Aventis Ireland Limited T/A SANOFI | Levofloxacin |
| Telmisartan/Hydrochlorothiazide Rowa 40mg/12.5mg Tablets PA0074/081/001 Rowa Pharmaceuticals Limited | Telmisartan & hydrochlorothiazide |
| Telmisartan Rowa 20mg Tablets PA0074/078/001 Rowa Pharmaceuticals Limited | Telmisartan |
Newly notified shortages
The HPRA has been notified of a shortage of the following products:
| Product | Active Ingredient(s) |
| Bendamustine HCl 100 mg Powder for Concentrate for Solution for Infusion PA2059/028/002 Fresenius Kabi Deutschland GmbH | Bendamustine |
| Cisplatin 1 mg/ml Concentrate for Solution for Infusion (50ml presentation only) PA0822/199/001 Pfizer Healthcare Ireland | Cisplatin |
| CONBRIZA 20 mg film-coated tablets EU/1/09/511/001 Pfizer Europe MA EEIG | Bazedoxifene |
| Donepezil Teva 5 mg Film-coated Tablets PA0749/194/001 Teva Pharma B.V. | Donepezil |
| Dozept 5mg Film Coated Tablets PA0711/141/001 Rowex Ltd | Donepezil |
| Flucloxacillin 1000mg Powder for solution for injection/infusion PA1862/003/003 Ibigen Srl | Flucloxacillin |
| Genotropin MiniQuick 0.6mg powder and solvent for solution for injection PA0822/128/005 Pfizer Healthcare Ireland | Somatropin |
| Genotropin MiniQuick 1mg powder and solvent for solution for injection PA0822/128/007 Pfizer Healthcare Ireland | Somatropin |
| Lispril-Hydrochlorothiazide 10 mg/12.5 mg Tablets PA0711/051/001 Rowex Ltd | Lisinopril & hydrochlorothiazide |
| Mirap 15mg Film Coated Tablets PA0711/062/001 Rowex Ltd | Mirtazapine |
| Ramipril Teva Pharma 2.5mg Tablets PA0749/177/002 Teva Pharma B.V. | Ramipril |
| TRITACE 1.25 mg Tablets PA0540/084/005 Sanofi-Aventis Ireland Limited T/A SANOFI | Ramipril |
| Valganciclovir Accord 450 mg film-coated tablets PA2315/179/001 Accord Healthcare Ireland Ltd. | Valganciclovir |
| Valsartan Teva 80 mg Film-coated Tablets PA0749/084/002 Teva Pharma B.V. | Valsartan |
| Valsartan Teva 160 mg Film-coated Tablets PA0749/084/003 Teva Pharma B.V. | Valsartan |
| Zismirt 30mg Film-coated tablets PA0577/059/001 McDermott Laboratories Ltd., T/A Gerard Laboratories | Mirtazapine |
| Zorclone 7.5 mg Film-Coated Tablets PA1986/080/001 Teva B.V. | Zopiclone |
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.